May 1, 2025 08:00AM
Apr 24, 2025 09:03AM
Apr 24, 2025 09:00AM
Mar 28, 2025 06:35AM
Mar 27, 2025 07:00AM
Mar 27, 2025 07:00AM
Mar 27, 2025 07:00AM Equillium Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate and Clinical Highlights
Oct 31, 2024 04:29PM
Jun 4, 2024 08:00AM
Jun 4, 2024 08:00AM
Mar 4, 2022 08:00AM
Dec 7, 2021 09:00AM
Nov 10, 2021 04:01PM
Aug 11, 2021 04:34PM Equillium (EQ) Announces Update to EQUALISE Study of Itolizumab in Patients with Systemic Lupus Erythematosus and Lupus Nephritis
Aug 11, 2021 04:00PM
Aug 10, 2021 04:01PM
Jul 13, 2021 09:25AM
Jul 12, 2021 05:59PM
Jul 12, 2021 05:37PM
Jul 12, 2021 04:01PM
Jul 12, 2021 04:01PM Equillium Announces Plans to Initiate Phase 3 Pivotal Study of Itolizumab in First-line Treatment of Acute Graft-Versus-Host Disease Following End-of-Phase 1 Meeting with the FDA
Jun 11, 2021 07:01AM
Jun 11, 2021 07:00AM
Jun 11, 2021 07:00AM
Mar 31, 2021 09:22AM
Mar 30, 2021 05:42PM
Dec 21, 2020 08:00AM
Dec 21, 2020 08:00AM Equillium Appoints Industry Veteran, Dolca Thomas, M.D. as Executive Vice President of Research & Development and Chief Medical Officer
Nov 6, 2020 08:36AM
Nov 6, 2020 08:35AM
Nov 6, 2020 08:35AM
Nov 4, 2020 08:35AM
Nov 4, 2020 08:35AM
Oct 30, 2020 09:29AM
Oct 29, 2020 06:01PM After-Hours Stock Movers 10/29: (EQ) (PLT) (GOOGL) Higher; (AXGT) (COLM) (TWTR) (AAPL) Lower (more...)
Oct 29, 2020 04:51PM
Oct 29, 2020 04:13PM
Oct 29, 2020 04:13PM
Sep 15, 2020 08:07AM
Sep 15, 2020 08:07AM
Sep 15, 2020 08:07AM
Aug 18, 2020 04:05PM Equillium Announces Closing of Public Offering of Common Stock
Aug 18, 2020 04:05PM
Aug 14, 2020 05:51AM
Aug 13, 2020 09:42PM
Aug 13, 2020 09:42PM
Aug 13, 2020 04:03PM
Aug 13, 2020 04:02PM
Aug 13, 2020 04:02PM Equillium Announces Proposed Public Offering of Common Stock
Aug 12, 2020 08:37AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All